Drug discovery: a job too complex for academia or industry alone?

5 - 6 January 2012
Two-day conference
Oxford, UK

The objective of this conference is to bring together those concerned about drug discovery (academia, industry, biotech, funders, charities, patient groups) to debate the bottlenecks hindering innovation and real tangible results. It will consist of six different discussion panels. Short talks by the panellists (15 min each) will be followed by critical and direct questioning by the chairs, who will also encourage participation from the audience.

Organiser: Structural Genomics Consortium (SGC)